Cargando…
国产达沙替尼二线治疗慢性髓性白血病慢性期患者的疗效和安全性分析
OBJECTIVE: To investigate the efficiency and safety of domestic tyrosine kinase inhibitor (TKI) dasatinib (Yinishu) as second-line treatment for patients with chronic myeloid leukemia in chronic phase (CML-CP). METHODS: A retrospective analysis of clinical data of CML-CP patients who received domest...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342660/ https://www.ncbi.nlm.nih.gov/pubmed/30831623 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.02.002 |